Acute-phase proteins and serologic profiles of chagasic children from an endemic area in Bolivia

American Journal of Tropical Medicine and Hygiene

Volumn 54, Issue 2, 1996, Pages 154-161

  Medrano Mercado, N ^a,b   Luz, M R M P ^a   Torrico, F ^b   Tapia, G ^b   Van Leuven, F ^c   Araujo Jorge, T C ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b UNIVERSIDAD MAYOR DE SAN SIMÓN   (Bolivia)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 2 MACROGLOBULIN; C REACTIVE PROTEIN; GALACTOSE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ANTIBODY PRODUCTION; ARTICLE; BOLIVIA; CHAGAS DISEASE; CHILD; DISEASE COURSE; ENDEMIC DISEASE; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; PROGNOSIS; SEROLOGY; TRYPANOSOMA CRUZI;

TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0029990976     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1996.54.154     Document Type: Article

References (30)

1. Brener Z, Krettli AU, 1990. Immunology of Chagas' disease. Wyler DJ, ed. Modern Parasite Biology: Cellular, Immunological and Molecular Aspects. San Francisco: W. H. Freeman & Co., 247-261.
2. World Health Organization, 1990. Chagas' disease frequency and geographical distribution. Wkly Epidemiol Rec 34: 527-561.
3. Carrasco R, Miguez H, Camacho C, Echalar L, Revollo S, Ampuero T, Dedet J-P, 1990. Prevalence of Trypanosoma cruzi in blood banks of seven departments of Bolivia. Mem Inst Oswaldo Cruz 85: 69-73.
4. Alonso JM, Manguiaterra ML, Storni PM, Szarfman A, 1977. Estudios serologicos en un area rural del Chaco. Medicina (B Aires) 37: 80-81.
5. Dias JCF, 1984. Acute Chagas' disease. Mem Inst Oswaldo Cruz 79 (suppl): 85-91.
6. Schmunis GA, Szarfman A, Coarasa L, Guilleron C, Peralta JM, 1980. Anti-Trypanosoma cruzi agglutinins in acute human Chagas' disease. Am J Trop Med Hyg 29: 170-178.
7. Pless M, Juranek D, Kozarsky P, Steurer F, Tapia G, Bermudez H, 1992. The epidemiology of Chagas' disease in a hyperendemic area of Cochabamba, Bolivia: a clinical study including electrocardiography, seroreactivity to Trypanosoma cruzi, xenodiagnosis, and domiciliary triatomine distribution. Am J Trop Med Hyg 47: 539-546.
8. Camargo ME, Amato Neto V, 1974. Anti-Trypanosoma cruzi IgM antibodies as serological evidence of recent infection. Rev Inst Med Trop Sao Paulo 56: 200-202.
9. Gazzinelli RT, Galvao LCM, Dias JCP, Gazzinelli G, Brener Z, 1988. Anti-laminin antibodies in acute Chagas' disease. Trans R Soc Trop Med Hyg 82: 574-576.
10. Grauen MR, Houssayer M, Hontebeyrie-Joskowciz M, 1993. Trypanosoma cruzi infection enhances polyreactivity antibody response in an acute case of human Chagas' disease. Clin Exp Ummunol 93: 85-92
11. Koj A, 1985. Definition and classification of acute phase proteins. Cordon AH, Koj A, eds. The Acute Phase Response to Injury and Infection. Amsterdam: Elsevier, 139-144.
12. Isaac L, Pereira M, Santos M, Sampaio E, Lima N, Lage MJ, Araujo-Jorge TC, 1990. Trypanosoma cruzi: plasma levels of alpha-2-macroglobulin during experimental murine infections with reticulotropic and myotropic strains. Parasitol Res 76: 726-728.
13. Araujo-Jorge TC, Lage M-J, Rivera M-T, Carlier Y, Van Leuven F, 1992. Trypanosoma cruzi: enhanced alpha-macroglobulin levels correlate with the resistance of Balb/cj mice to acute infection. Parasitol Res 78: 215-221.
14. Luz MRMP, Van Leuven F, Araujo-Jorge T-C, 1994. Heterogeneity in the plasma levels of two acute phase proteins in mice from inbred strains infected with Trypanosoma cruzi. Parasitol Res 80: 439-441.
15. Scharfstein J, Barcinski MA, Leon L, 1982. Induction of acute-phase protein serum amyloid P in experimental Chagas' disease. Infect Immun 35: 46-51.
16. Van Leuven F, 1982. Human α2-macroglobulin, structure and function. Trends Biochem Sci 7: 185-187.
17. Kolb-Bachofen V, 1991. A review on the biological properties of C-reactive protein. Immunobiology 193: 133-145.
18. Medrano NM, Luz MRMP, Cabello PH, Tapia GT, Van Leuven F, Araujo-Jorge TC, 1995. Acute Chagas' disease: plasma levels of alpha-2-macroglobulin and C-reactive protein in children under 13 years in a highly endemic area of Bolivia. J Trop Pediatr: (in press).
19. Torrico RA, 1958. Casuistica de la enfermedad de Chagas en Bolivia. An Lab Cent 4: 3-7.
20. Velasquez E, Reyes L, Thors C, Miettinen A, Chinchilla M, Linder E, 1993. Auto antibodies give false positive reactions in the serodiagnosis of Trypanosoma cruzi infection. Trans R Soc Trop Med Hyg 87: 35.
21. Spiegel MR, 1969. Estatistica. Second edition. Rio de Janeiro: Ao Livro Tecnico Ed.
22. Raun NE, Moller BB, Back U, Gad J, 1982. On individual reference intervals based on a longitudinal study of plasma proteins and lipids in healthy subjects and their possible clinical application. Clin Chem 28: 294-300.
23. Van Gool J, 1983. Profiles of acute phase reactants and clinical significance of alpha-2-macroglobulin in acute hepatitis B. Inflammation 7: 227-289.
24. Van Gool J, Van Vugt H, De Bont E, 1990. Alpha-macroglobulin and fibrinogen modulate inflammatory edema in man. Inflammation 14: 275-283.
25. Gazzinelli RT, 1991. Natural anti-Gal antibodies prevent, rather than cause, autoimmunity in human Chagas' disease. Res Immunol 142: 164-167.
26. Teixeira VPA, Martins F, Almeida HO, Soares S, Souza HM, Morais CA, 1987. Sistema ABO a forma clinica doenca de Chagas cronica. Rev Soc Bras Med Trop 20: 163-168.
27. Galili U, Buehler J, Shohet SB, Macher BA, 1987. The human natural anti-Gal IgG. III. The subtlety of immune tolerance in man as demonstrated by crossreactivity between the natural anti-Gal and anti-B antibodies. J Exp Med 165: 693-704.
28. Gazzinelli RT, Galvao LCH, Cancado JR, Cardoso J, Krettli AU, Brener Z, Gazzinelli G, 1988. Anti-Trypanosoma and anti-laminin antibodies in chagasic patients submitted to specific treatment. J Clin Microbiol 26: 1795-1800.
29. Coca ER, Soruco MG, Crespo C, Olivera L, Pardo OR, Rosales LA, Torres TH, 1993. Grupos sanguineos y el factor Rh en el departamento de Cochabamba. Gac Med Bol 15: 5-9.
30. Roychoudhury AK, Nei M, 1988. Polymorphic genes: World Distribution. New York: Oxford University Press.